This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Thierry Guillaudeux
Chief Scientific Officer at Kineta Inc


Dr Thierry Guillaudeux CSO at Kineta has over 30 years of experience in Immuno-Oncology in France and in the USA, with a strong executive background in academia, heading a research laboratory of the French National Institute of Health. Dr Guillaudeux is leading the Kineta’s Immuno-Oncology programs from discovery to clinical trial. He also leads the scientific strategy for the selection of new innovative Immuno-Oncology programs at Kineta. His fields of expertise are B cell lymphomas, lung cancer and the tumor microenvironment. Dr Guillaudeux received his PhD in Immuno-Oncology from the University of Rennes and achieved his post-doctorate at the Fred Hutchinson Cancer Research Center in Seattle where he was responsible for the sequencing of the Human Major Histocompatibility Complex.

Agenda Sessions

  • KVA12.1 a VISTA Blocking Immunotherapy